Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119784685> ?p ?o ?g. }
- W2119784685 endingPage "1777" @default.
- W2119784685 startingPage "1770" @default.
- W2119784685 abstract "Leukocyte function associated antigen-1 (LFA-1) has a multifaceted role in the immune response, including adhesion and trafficking of leukocytes, stabilizing the immune synapse of the MHC-TCR complex and providing costimulation signals. Monoclonal antibodies to the CD11a chain of LFA-1 have been seen to result in effective immunosuppression in experimental models. Efalizumab, a humanized IgG1 anti-CD11a, is approved for use in psoriasis and may provide effective immunosuppression in organ transplantation. Thirty-eight patients undergoing their first living donor or deceased renal transplant were randomized to receive efalizumab 0.5 or 2 mg/kg weekly subcutaneously for 12 weeks. Patients were maintained on full dose cyclosporine, mycophenolate mofetil and steroids or half dose cyclosporine, sirolimus and prednisone. At 6 months following transplant patient survival was 97% and graft survival was 95%. Clinical biopsy-proven acute rejection in the first 6 months after transplantation was confirmed in 4 of 38 patients (11%). Three patients (8%) developed post transplant lymphoproliferative disease, all treated with the higher dose efalizumab and full dose cyclosporine. The two doses of efalizumab resulted in comparable saturation and modulation of CD11a. This phase II trial suggests that efalizumab may warrant further investigation in transplantation." @default.
- W2119784685 created "2016-06-24" @default.
- W2119784685 creator A5016101065 @default.
- W2119784685 creator A5017078172 @default.
- W2119784685 creator A5021095117 @default.
- W2119784685 creator A5026247496 @default.
- W2119784685 creator A5026789430 @default.
- W2119784685 creator A5039370214 @default.
- W2119784685 creator A5042236941 @default.
- W2119784685 creator A5055641686 @default.
- W2119784685 creator A5056116515 @default.
- W2119784685 creator A5077408832 @default.
- W2119784685 creator A5090036141 @default.
- W2119784685 date "2007-07-01" @default.
- W2119784685 modified "2023-09-26" @default.
- W2119784685 title "A Phase I/II Randomized Open-Label Multicenter Trial of Efalizumab, a Humanized Anti-CD11a, Anti-LFA-1 in Renal Transplantation" @default.
- W2119784685 cites W149222597 @default.
- W2119784685 cites W1581554632 @default.
- W2119784685 cites W1595539869 @default.
- W2119784685 cites W1637072617 @default.
- W2119784685 cites W1963504100 @default.
- W2119784685 cites W1967143763 @default.
- W2119784685 cites W1973645636 @default.
- W2119784685 cites W1980161688 @default.
- W2119784685 cites W1986093977 @default.
- W2119784685 cites W1988652338 @default.
- W2119784685 cites W1990788669 @default.
- W2119784685 cites W2019538815 @default.
- W2119784685 cites W2023748102 @default.
- W2119784685 cites W2028146382 @default.
- W2119784685 cites W2032785800 @default.
- W2119784685 cites W2036488279 @default.
- W2119784685 cites W2038737345 @default.
- W2119784685 cites W2047291715 @default.
- W2119784685 cites W2047427464 @default.
- W2119784685 cites W2051598816 @default.
- W2119784685 cites W2052307789 @default.
- W2119784685 cites W2060311860 @default.
- W2119784685 cites W2062308186 @default.
- W2119784685 cites W2062560122 @default.
- W2119784685 cites W2065459312 @default.
- W2119784685 cites W2087061270 @default.
- W2119784685 cites W2107346812 @default.
- W2119784685 cites W2112333205 @default.
- W2119784685 cites W2116619489 @default.
- W2119784685 cites W2118061894 @default.
- W2119784685 cites W2119107344 @default.
- W2119784685 cites W2137780217 @default.
- W2119784685 cites W2144856110 @default.
- W2119784685 cites W2151743773 @default.
- W2119784685 cites W2152976783 @default.
- W2119784685 cites W2166556012 @default.
- W2119784685 cites W2170264508 @default.
- W2119784685 cites W2308367073 @default.
- W2119784685 cites W2333378480 @default.
- W2119784685 cites W4238785086 @default.
- W2119784685 cites W4243010265 @default.
- W2119784685 doi "https://doi.org/10.1111/j.1600-6143.2007.01845.x" @default.
- W2119784685 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17564637" @default.
- W2119784685 hasPublicationYear "2007" @default.
- W2119784685 type Work @default.
- W2119784685 sameAs 2119784685 @default.
- W2119784685 citedByCount "158" @default.
- W2119784685 countsByYear W21197846852012 @default.
- W2119784685 countsByYear W21197846852013 @default.
- W2119784685 countsByYear W21197846852014 @default.
- W2119784685 countsByYear W21197846852015 @default.
- W2119784685 countsByYear W21197846852016 @default.
- W2119784685 countsByYear W21197846852017 @default.
- W2119784685 countsByYear W21197846852018 @default.
- W2119784685 countsByYear W21197846852019 @default.
- W2119784685 countsByYear W21197846852020 @default.
- W2119784685 countsByYear W21197846852021 @default.
- W2119784685 countsByYear W21197846852022 @default.
- W2119784685 countsByYear W21197846852023 @default.
- W2119784685 crossrefType "journal-article" @default.
- W2119784685 hasAuthorship W2119784685A5016101065 @default.
- W2119784685 hasAuthorship W2119784685A5017078172 @default.
- W2119784685 hasAuthorship W2119784685A5021095117 @default.
- W2119784685 hasAuthorship W2119784685A5026247496 @default.
- W2119784685 hasAuthorship W2119784685A5026789430 @default.
- W2119784685 hasAuthorship W2119784685A5039370214 @default.
- W2119784685 hasAuthorship W2119784685A5042236941 @default.
- W2119784685 hasAuthorship W2119784685A5055641686 @default.
- W2119784685 hasAuthorship W2119784685A5056116515 @default.
- W2119784685 hasAuthorship W2119784685A5077408832 @default.
- W2119784685 hasAuthorship W2119784685A5090036141 @default.
- W2119784685 hasBestOaLocation W21197846851 @default.
- W2119784685 hasConcept C126322002 @default.
- W2119784685 hasConcept C203014093 @default.
- W2119784685 hasConcept C2779015954 @default.
- W2119784685 hasConcept C2779528694 @default.
- W2119784685 hasConcept C2779719350 @default.
- W2119784685 hasConcept C2780252810 @default.
- W2119784685 hasConcept C2780564577 @default.
- W2119784685 hasConcept C2780969348 @default.
- W2119784685 hasConcept C2909675724 @default.
- W2119784685 hasConcept C2911091166 @default.